Characterization of simian immunodeficiency virus (SIV) that induces SIV encephalitis in rhesus macaques with high frequency: Role of TRIM5 and major histocompatibility complex genotypes and early entry to the brain

Journal of Virology

Volumn 88, Issue 22, 2014, Pages 13201-13211

  Matsuda, Kenta ^a   Dang, Que ^a   Brown, Charles R ^b   Keele, Brandon F ^c   Wu, Fan ^a   Ourmanov, Ilnour ^a   Goeken, Robert ^a   Whitted, Sonya ^a   Riddick, Nadeene E ^a   Buckler White, Alicia ^a   Hirsch, Vanessa M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b MEDIMMUNE   (United States)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRIPARTITE MOTIF PROTEIN 5; PROTEIN; TRIM5(ALPHA) PROTEIN, RHESUS MONKEY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENOTYPE; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; PROTEIN FUNCTION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS ENCEPHALITIS; VIRUS ENCEPHALITIS; VIRUS ENTRY; VIRUS REPLICATION; VIRUS VIRULENCE; ANIMAL; BRAIN; COMPLICATION; DNA SEQUENCE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MOLECULAR GENETICS; PHYSIOLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY; VIRULENCE;

ANIMALS; BRAIN; ENCEPHALITIS, VIRAL; GENOTYPE; LENTIVIRUSES, PRIMATE; MACACA MULATTA; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR SEQUENCE DATA; PROTEINS; SEQUENCE ANALYSIS, DNA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRULENCE;

EID: 84908388848     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01996-14     Document Type: Article

References (43)

1. Kolson DL, Gonzalez-Scarano F. 2000. HIV and HIV dementia. J. Clin. Invest. 106:11-13. http://dx.doi.org/10.1172/JCI10553.
2. Navia BA, Jordan BD, Price RW. 1986. The AIDS dementia complex. I. Clinical features. Ann. Neurol. 19:517-524.
3. Navia BA, Cho ES, Petito CK, Price RW. 1986. The AIDS dementia complex. II. Neuropathology. Ann. Neurol. 19:525-535. http://dx.doi.org/10.1002/ana.410190603.
4. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. 1988. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586-592. http://dx.doi.org/10.1126/science.3277272.
5. Heaton RK, Clifford DB, Franklin DR, Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group. 2010. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087-2096. http://dx.doi.org/10.1212/WNL.0b013e318200d727.
6. Valcour V, Watters MR, Williams AE, Sacktor N, McMurtray A, Shikuma C. 2008. Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy. J. Neurovirol. 14:362-367. http://dx.doi.org/10.1080/13550280802216494.
7. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group, HNRC Group. 2011. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol. 17:3-16. http://dx.doi.org/10.1007/s13365-010-0006-1.
8. Cysique LA, Maruff P, Brew BJ. 2004. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre-and posthighly active antiretroviral therapy eras: a combined study of two cohorts. J. Neurovirol. 10:350-357. http://dx.doi.org/10.1080/13550280490521078.
9. Lackner AA, Vogel P, Ramos RA, Kluge JD, Marthas M. 1994. Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. Am. J. Pathol. 145:428-439.
10. Bissel SJ, Wang G, Trichel AM, Murphey-Corb M, Wiley CA. 2006. Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis. Am. J. Pathol. 168:1553-1569. http://dx.doi.org/10.2353/ajpath.2006.050240.
11. Matsuda K, Brown CR, Foley B, Goeken R, Whitted S, Dang Q, Wu F, Plishka R, Buckler-White A, Hirsch VM. 2013. Laser capture microdissection assessment of virus compartmentalization in the central nervous systems of macaques infected with neurovirulent simian immunodeficiency virus. J. Virol. 87:8896-8908. http://dx.doi.org/10.1128/JVI.00874-13.
12. Dang Q, Goeken RM, Brown CR, Plishka RJ, Buckler-White A, Byrum R, Foley BT, Hirsch VM. 2008. Adaptive evolution of simian immunodeficiency viruses isolated from 2 conventional-progressor macaques with encephalitis. J. Infect. Dis. 197:1695-1700. http://dx.doi.org/10.1086/588671.
13. Silva AC, Rodrigues BS, Micheletti AM, Tostes S, Jr, Meneses AC, Silva-Vergara ML, Adad SJ. 2012. Neuropathology of AIDS: an autopsy review of 284 cases from Brazil comparing the findings pre-and post-HAART (highly active antiretroviral therapy) and pre-and postmortem correlation. AIDS Res. Treat. 2012:186850. http://dx.doi.org/10.1155/2012/186850.
14. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, Irwin CE, Safrit JT, Mittler J, Weinberger L, Kostrikis LG, Zhang L, Perelson AS, Ho DD. 1999. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189:991-998. http://dx.doi.org/10.1084/jem.189.6.991.
15. Ortiz AM, Klatt NR, Li B, Yi Y, Tabb B, Hao XP, Sternberg L, Lawson B, Carnathan PM, Cramer EM, Engram JC, Little DM, Ryzhova E, Gonzalez-Scarano F, Paiardini M, Ansari AA, Ratcliffe S, Else JG, Brenchley JM, Collman RG, Estes JD, Derdeyn CA, Silvestri G. 2011. Depletion of CD4(+) T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques. J. Clin. Invest. 121:4433-4445. http://dx.doi.org/10.1172/JCI46023.
16. Strickland SL, Gray RR, Lamers SL, Burdo TH, Huenink E, Nolan DJ, Nowlin B, Alvarez X, Midkiff CC, Goodenow MM, Williams K, Salemi M. 2012. Efficient transmission and persistence of low-frequency SIVmac251 variants in CD8-depleted rhesus macaques with different neuropathology. J. Gen. Virol. 93:925-938. http://dx.doi.org/10.1099/vir.0.039586-0.
17. Annamalai L, Bhaskar V, Pauley DR, Knight H, Williams K, Lentz M, Ratai E, Westmoreland SV, Gonzalez RG, O'Neil SP. 2010. Impact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques. Am. J. Pathol. 177:777-791. http://dx.doi.org/10.2353/ajpath.2010.091248.
18. Anderson MG, Hauer D, Sharma DP, Joag SV, Narayan O, Zink MC, Clements JE. 1993. Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques. Virology 195:616-626. http://dx.doi.org/10.1006/viro.1993.1413.
19. Zink MC, Suryanarayana K, Mankowski JL, Shen A, Piatak M, Jr, Spelman JP, Carter DL, Adams RJ, Lifson JD, Clements JE. 1999. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J. Virol. 73:10480-10488.
20. Flaherty MT, Hauer DA, Mankowski JL, Zink MC, Clements JE. 1997. Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J. Virol. 71:5790-5798.
21. Baskin GB, Martin LN, Rangan SR, Gormus BJ, Murphey-Corb M, Wolf RH, Soike KF. 1986. Transmissible lymphoma and simian acquired immunodeficiency syndrome in rhesus monkeys. JNCI 77:127-139.
22. Baskin GB, Murphey-Corb M, Watson EA, Martin LN. 1988. Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/delta. Vet. Pathol. 25:456-467. http://dx.doi.org/10.1177/030098588802500609.
23. Kuwata T, Dehghani H, Brown CR, Plishka R, Buckler-White A, Igarashi T, Mattapallil J, Roederer M, Hirsch VM. 2006. Infectious molecular clones from a simian immunodeficiency virus-infected rapidprogressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo. J. Virol. 80:1463-1475. http://dx.doi.org/10.1128/JVI.80.3.1463-1475.2006.
24. Dang Q, Whitted S, Goeken RM, Brenchley JM, Matsuda K, Brown CR, Lafont BA, Starost MF, Iyengar R, Plishka RJ, Buckler-White A, Hirsch VM. 2012. Development of neurological disease is associated with increased immune activation in simian immunodeficiency virus-infected macaques. J. Virol. 86:13795-13799. http://dx.doi.org/10.1128/JVI.02174-12.
25. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
26. Keele BF, Li H, Learn GH, Hraber P, Giorgi EE, Grayson T, Sun C, Chen Y, Yeh WW, Letvin NL, Mascola JR, Nabel GJ, Haynes BF, Bhattacharya T, Perelson AS, Korber BT, Hahn BH, Shaw GM. 2009. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J. Exp. Med. 206:1117-1134. http://dx.doi.org/10.1084/jem.20082831.
27. Wu F, Ourmanov I, Kuwata T, Goeken R, Brown CR, Buckler-White A, Iyengar R, Plishka R, Aoki ST, Hirsch VM. 2012. Sequential evolution and escape from neutralization of simian immunodeficiency virus SIVsmE660 clones in rhesus macaques. J. Virol. 86:8835-8847. http://dx.doi.org/10.1128/JVI.00923-12.
28. - T cells in multiple natural hosts of simian immunodeficiency virus. J. Virol. 85:8702-8708. http://dx.doi.org/10.1128/JVI.00332-11.
29. Kirmaier A, Wu F, Newman RM, Hall LR, Morgan JS, O'Connor S, Marx PA, Meythaler M, Goldstein S, Buckler-White A, Kaur A, Hirsch VM, Johnson WE. 2010. TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS biology 8(8):e1000462. http://dx.doi.org/10.1371/journal.pbio.1000462.
30. Wu F, Kirmaier A, Goeken R, Ourmanov I, Hall L, Morgan JS, Matsuda K, Buckler-White A, Tomioka K, Plishka R, Whitted S, Johnson W, Hirsch VM. 2013. TRIM5 alpha drives SIVsmm evolution in rhesus macaques. PLoS Pathog. 9:e1003577. http://dx.doi.org/10.1371/journal.ppat.1003577.
31. Mothé BR, Weinfurter J, Wang C, Rehrauer W, Wilson N, Allen TM, Allison DB, Watkins DI. 2003. Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol. 77:2736-2740. http://dx.doi.org/10.1128/JVI.77.4.2736-2740.2003.
32. Yant LJ, Friedrich TC, Johnson RC, May GE, Maness NJ, Enz AM, Lifson JD, O'Connor DH, Carrington M, Watkins DI. 2006. The highfrequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol. 80:5074-5077. http://dx.doi.org/10.1128/JVI.80.10.5074-5077.2006.
33. Allen TM, Sidney J, del Guercio MF, Glickman RL, Lensmeyer GL, Wiebe DA, DeMars R, Pauza CD, Johnson RP, Sette A, Watkins DI. 1998. Characterization of the peptide binding motif of a rhesusMHCclass I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. J. Immunol. 160:6062-6071.
34. Zink MC, Amedee AM, Mankowski JL, Craig L, Didier P, Carter DL, Munoz A, Murphey-Corb M, Clements JE. 1997. Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am. J. Pathol. 151:793-803.
35. Guillemin G, Croitoru J, Le Grand RL, Franck-Duchenne M, Dormont D, Boussin FD. 2000. Simian immunodeficiency virus mac251 infection of astrocytes. J. Neurovirol. 6:173-186. http://dx.doi.org/10.3109/13550280009015821.
36. Tornatore C, Chandra R, Berger JR, Major EO. 1994. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44:481-487. http://dx.doi.org/10.1212/WNL.44.3_Part_1.481.
37. Saito Y, Sharer LR, Epstein LG, Michaels J, Mintz M, Louder M, Golding K, Cvetkovich TA, Blumberg BM. 1994. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44:474-481. http://dx.doi.org/10.1212/WNL.44.3_Part_1.474.
38. Neumann M, Felber BK, Kleinschmidt A, Froese B, Erfle V, Pavlakis GN, Brack-Werner R. 1995. Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J. Virol. 69:2159-2167.
39. Loffredo JT VL, Watkins DI. 2006/2007. Beyond Mamu-A*01+ Indian rhesus macaques: continued discovery of new MHC class I molecules that bind epitopes from the simian AIDS viruses. HIV Mol. Immunol. 2006/2007:29-51.
40. Mankowski JL, Queen SE, Fernandez CS, Tarwater PM, Karper JM, Adams RJ, Kent SJ. 2008. Natural host genetic resistance to lentiviral CNS disease: a neuroprotective MHC class I allele in SIV-infected macaques. PLoS One 3:e3603. http://dx.doi.org/10.1371/journal.pone.0003603.
41. Clements JE, Babas T, Mankowski JL, Suryanarayana K, Piatak M, Jr, Tarwater PM, Lifson JD, Zink MC. 2002. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J. Infect. Dis. 186:905-913. http://dx.doi.org/10.1086/343768.
42. Stephens EB, Singh DK, Kohler ME, Jackson M, Pacyniak E, Berman NE. 2003. The primary phase of infection by pathogenic simian-human immunodeficiency virus results in disruption of the blood-brain barrier. AIDS Res. Hum. Retroviruses 19:837-846. http://dx.doi.org/10.1089/088922203322493003.
43. Afonso PV, Ozden S, Cumont MC, Seilhean D, Cartier L, Rezaie P, Mason S, Lambert S, Huerre M, Gessain A, Couraud PO, Pique C, Ceccaldi PE, Romero IA. 2008. Alteration of blood-brain barrier integrity by retroviral infection. PLoS Pathog. 4:e1000205. http://dx.doi.org/10.1371/journal.ppat.1000205.